These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20740682)

  • 1. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines.
    Ausar SF; Chan J; Hoque W; James O; Jayasundara K; Harper K
    J Pharm Sci; 2011 Feb; 100(2):431-40. PubMed ID: 20740682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants.
    Peek LJ; Martin TT; Elk Nation C; Pegram SA; Middaugh CR
    J Pharm Sci; 2007 Mar; 96(3):547-57. PubMed ID: 17080408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high-throughput screening platform to study the adsorption of antigens onto aluminum-containing adjuvants.
    Jully V; Moniotte N; Mathot F; Lemoine D; Préat V
    J Pharm Sci; 2015 Feb; 104(2):557-65. PubMed ID: 25470455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
    Dasnoy S; Le Bras V; Préat V; Lemoine D
    Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.
    Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF
    Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine.
    Peek LJ; Brey RN; Middaugh CR
    J Pharm Sci; 2007 Jan; 96(1):44-60. PubMed ID: 16998874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
    Levesque PM; de Alwis U
    Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.
    Wittayanukulluk A; Jiang D; Regnier FE; Hem SL
    Vaccine; 2004 Mar; 22(9-10):1172-6. PubMed ID: 15003645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
    Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
    PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine.
    Markham AP; Barrett BS; Esfandiary R; Picking WL; Picking WD; Joshi SB; Middaugh CR
    J Pharm Sci; 2010 Nov; 99(11):4497-509. PubMed ID: 20845449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.
    Jully V; Mathot F; Moniotte N; Préat V; Lemoine D
    J Pharm Sci; 2016 Jun; 105(6):1829-1836. PubMed ID: 27238481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF
    Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.
    Vessely C; Estey T; Randolph TW; Henderson I; Nayar R; Carpenter JF
    J Pharm Sci; 2007 Sep; 96(9):2375-89. PubMed ID: 17518359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
    Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
    Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.
    Agarwal S; Hickey JM; McAdams D; White JA; Sitrin R; Khandke L; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):476-487. PubMed ID: 31589875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical Characterization and Thermal Stability of Pneumococcal Histidine Triad Protein D in the Presence of Zinc and Manganese.
    Ausar SF; Jayasundara K; Akawi L; Roque C; Sheung A; Hu J; Kirkitadze M; Rahman N
    J Pharm Sci; 2017 Oct; 106(10):2979-2987. PubMed ID: 28624420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation.
    Colaprico A; Senesi S; Ferlicca F; Brunelli B; Ugozzoli M; Pallaoro M; O'Hagan DT
    Vaccine; 2020 Apr; 38(19):3600-3609. PubMed ID: 32063436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.